Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes Mellitus

Boston University School of Medicine, 88 East Newton Street, Boston, MA 02118., USA.
Circulation (Impact Factor: 14.95). 07/2011; 124(4):444-53. DOI: 10.1161/CIRCULATIONAHA.110.014506
Source: PubMed

ABSTRACT Endothelial dysfunction contributes to the development of atherosclerosis in patients with diabetes mellitus, but the mechanisms of endothelial dysfunction in this setting are incompletely understood. Recent studies have shown altered mitochondrial dynamics in diabetes mellitus with increased mitochondrial fission and production of reactive oxygen species. We investigated the contribution of altered dynamics to endothelial dysfunction in diabetes mellitus.
We observed mitochondrial fragmentation (P=0.002) and increased expression of fission-1 protein (Fis1; P<0.0001) in venous endothelial cells freshly isolated from patients with diabetes mellitus (n=10) compared with healthy control subjects (n=9). In cultured human aortic endothelial cells exposed to 30 mmol/L glucose, we observed a similar loss of mitochondrial networks and increased expression of Fis1 and dynamin-related protein-1 (Drp1), proteins required for mitochondrial fission. Altered mitochondrial dynamics was associated with increased mitochondrial reactive oxygen species production and a marked impairment of agonist-stimulated activation of endothelial nitric oxide synthase and cGMP production. Silencing Fis1 or Drp1 expression with siRNA blunted high glucose-induced alterations in mitochondrial networks, reactive oxygen species production, endothelial nitric oxide synthase activation, and cGMP production. An intracellular reactive oxygen species scavenger provided no additional benefit, suggesting that increased mitochondrial fission may impair endothelial function via increased reactive oxygen species.
These findings implicate increased mitochondrial fission as a contributing mechanism for endothelial dysfunction in diabetic states.

Download full-text


Available from: Mai-Ann Duess, Aug 24, 2015
  • Source
    • "For example, exposure of ECs to free fatty acids, which upregulate in patients with metabolic syndrome, increases mROS (Du et al., 2006). Otherwise, hyperglycemia changes mitochondrial dynamics and increases mROS in ECs, while the normalization of blood sugar inhibits the progression of vascular damage (Nishikawa et al., 2000; Yu et al., 2006; Shenouda et al., 2011). ROS produced in the vascular microenvironment causes mitochondrial damage and dysfunction , which in turn amplifies this effect partly due to reduced ROS buffering capacity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondria are perhaps the most sophisticated and dynamic responsive sensing systems in eukaryotic cells. The role of mitochondria goes beyond their capacity to create molecular fuel and includes the generation of reactive oxygen species, the regulation of calcium, and the activation of cell death. In endothelial cells, mitochondria have a profound impact on cellular function under both healthy and diseased conditions. In this review, we summarize the basic functions of mitochondria in endothelial cells and discuss the roles of mitochondria in endothelial dysfunction and vascular diseases, including atherosclerosis, diabetic vascular dysfunction, pulmonary artery hypertension, and hypertension. Finally, the potential therapeutic strategies to improve mitochondrial function in endothelial cells and vascular diseases are also discussed, with a focus on mitochondrial-targeted antioxidants and calorie restriction.
    Frontiers in Physiology 05/2014; 5:175. DOI:10.3389/fphys.2014.00175 · 3.50 Impact Factor
  • Source
    • "superoxide), metabolites, gene and microRNA expression, epigenetic modifications, protein concentrations, microbiomes (oral, gut, skin, etc.) and other mechanistic biomarkers, which can then be related to physiological phenotypes of interest across preclinical models up to populations of humans (Casado-Vela et al. 2011; Donato et al. 2011; Shaw & Brettman, 2011; LaRocca et al. 2012; Pedersen & Febbraio, 2012; Jablonski et al. 2013; Kujala et al. 2013). Samples from animal models or human subjects can be studied ex vivo after incubation with stressors or pharmacological/genetic modulators of mechanistic pathways of interest (Shenouda et al. 2011; Fleenor et al. 2012), or studied in culture (Shaw & Brettman, 2011; Pedersen & Febbraio, 2012). If a humoral (circulating) factor is suspected, cells or tissues of interest can be treated "
    [Show abstract] [Hide abstract]
    ABSTRACT: The term 'translational research' was coined 20 years ago and has become a guiding influence in biomedical research. It refers to a process by which the findings of basic research are extended to the clinical research setting (bench to bedside) and then to clinical practice and eventually health policy (bedside to community). It is a dynamic, multidisciplinary research approach. The concept of translational physiology applies the translational research model to the physiological sciences. It differs from the traditional areas of integrative and clinical physiology by its broad investigative scope of basic research to community health. Translational physiology offers exciting opportunities, but presently is under-developed and -utilized. A key challenge will be to expand physiological research by extending investigations to communities of patients and healthy (or at risk) individuals. This will allow bidirectional physiological investigation throughout the translational continuum: basic research observations can be studied up to the population level, and mechanisms can be assessed by 'reverse translation' in clinical research settings and preclinical models based on initial observations made in populations. Examples of translational physiology questions, experimental approaches, roadblocks and strategies for promotion are discussed. Translational physiology provides a novel framework for physiology programs and an investigational platform for physiologists to study function from molecular events to public health. It holds promise for enhancing the completeness and societal impact of our work, while further solidifying the critical role of physiology in the biomedical research enterprise.
    The Journal of Physiology 06/2013; 591(14). DOI:10.1113/jphysiol.2013.253195 · 4.54 Impact Factor
  • Source
    • "Oxidative stress is characterized as a disturbance between free radicals and antioxidant balance in favour of prooxidants (Halliwell 1991). Reactive oxygen species are linked to the pathophysiology of several diseases including diabetes mellitus (Shenouda et al. 2011), atherosclerosis (Vogiatzi et al. 2009), neurodegenerative diseases (Henchcliffe and Beal 2008; Uttara et al. 2009), periodontitis (D'Aiuto et al. 2010), etc. Increased production of free radicals results in oxidative damage to large molecules, such as proteins, lipids, and DNA (Miricescu et al. 2011). A number of biochemical markers are used for quantification of oxidative stress in plasma in order to investigate the potential role of reactive oxygen species in the development of pathological changes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Several studies showed there are sex differences in oxidative stress. An observational study analysing oxidative stress markers in young healthy men and women is lacking. Moreover, it is unclear whether the differences are related to sex hormones. Aim: The primary goal was to analyse differences in oxidative stress markers with regard to sex in plasma of young healthy subjects and whether differences are related to sex hormones. The secondary study compared oxidative stress markers in plasma with salivary samples. Methods: Plasma and saliva samples were analysed from 158 young healthy probands. Established spectro-photometric/fluorometric methods were used to quantify oxidative stress markers. Sex hormones were measured using ELISA kits. Results: In plasma, malondialdehyde and advanced glycation end products were significantly higher in women. Advanced oxidation protein products and the ferric reducing ability of plasma were higher in men. Sex hormones were not associated with oxidative stress markers. In saliva, analysed markers of antioxidant status were higher in men, but no sex differences were found in other markers. Conclusion: Observed parameters showed marker-specific sex differences in plasma, but these differences were not related to sex hormones. Plasma and saliva concentrations of biomarkers did not correlate, reflecting oral but not systemic conditions.
    Annals of Human Biology 01/2013; 40(2). DOI:10.3109/03014460.2012.754495 · 1.15 Impact Factor
Show more